中成药研发概念近七个交易日股市资讯回顾:
2021-04-16复盘:普遍报涨
嘉应制药(6.240,0.420,7.216%)领涨,吉药控股(2.970,0.100,3.484%)、同仁堂(28.840,0.900,3.221%)等跟涨。
2021-04-15复盘:普遍报跌
同仁堂(27.960,-0.940,-3.253%)领跌,吉药控股(2.870,-0.050,-1.712%)、佛慈制药(7.370,-0.020,-0.271%)等跟跌。
2021-04-14复盘:普遍报涨
佛慈制药(7.390,0.160,2.213%)领涨,吉药控股(2.920,0.060,2.098%)、易明医药(8.760,0.160,1.860%)、振东制药(4.750,0.060,1.279%)等跟涨。
2021-04-13复盘:普遍报跌
吉药控股(2.860,-0.080,-2.721%)领跌,易明医药(8.600,-0.150,-1.714%)、佛慈制药(7.230,-0.120,-1.633%)、同仁堂(28.840,-0.270,-0.928%)、振东制药(4.690,-0.020,-0.425%)等跟跌。
2021-04-12复盘:普遍报涨
吉药控股(2.940,0.040,1.379%)领涨,吉药控股(2.940,0.040,1.379%)、同仁堂(29.100,0.040,0.138%)等跟涨。
2021-04-09复盘:普遍报涨
佛慈制药(7.250,0.180,2.546%)领涨,吉药控股(2.900,0.050,1.754%)、同仁堂(29.150,0.250,0.865%)、嘉应制药(5.580,0.040,0.722%)等跟涨。
2021-04-08复盘:普遍报跌
吉药控股(2.850,-0.100,-3.390%)领跌,振东制药(4.800,-0.160,-3.226%)、易明医药(8.830,-0.080,-0.898%)等跟跌。
本文选取数据仅作为参考,并不能全面、准确地反映任何一家企业的未来,并不构成投资建议,据此操作,风险自担。